Navigation Links
Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
Date:8/13/2013

LA JOLLA, Calif., Aug. 13, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the quarter ended June 30, 2013 and provided a summary of recent corporate highlights. 

"The second quarter was a period of significant progress for Regulus.  We continued to execute on our 'Road to the Clinic' strategy and are preparing for clinical development of RG-101, a GalNAc-conjugated anti-miR which targets miR-122 for HCV. We also made great progress across the pipeline, advancing additional proprietary and partnered programs and identifying attractive new opportunities to broaden our microRNA platform," said Kleanthis G. Xanthopoulos, Ph.D., President and CEO of Regulus.  "On the business front, we had a very productive quarter and recent period. We are pleased to have entered into an exclusive option agreement with Sanofi to negotiate the terms of a potential new relationship.  Additionally, we strengthened our balance sheet with a successful public offering which will enable us to accelerate our 'Road to the Clinic' goals, expand our microRNA therapeutic pipeline and increase our cash runway to fund our operations into 2017."

"These recent accomplishments have positioned us for an exciting period focused on scientific execution," said Neil W. Gibson, Ph.D., Chief Scientific Officer of Regulus.  "We look forward to entering the clinic with RG-101, nominating a second candidate for clinical development by the end of the year, and continuing to build a meaningful clinical pipeline based on microRNAs."Recent Corporate Highlights

  • Secured Rights to Proprietary Process for Manufacturing GalNAc Conjugates from Alnylam.  Regulus entered into an
    '/>"/>

  • SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
    2. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
    3. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
    4. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
    5. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
    6. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
    7. Regulus to Present at Future Leaders in the Biotech Industry Conference
    8. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
    9. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
    10. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
    11. Regulus to Present at Two Upcoming Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... TIJUANA, Mexico , Dec. 24, 2014 /PRNewswire/ ... treatment of its first patient in its study ... to the American Stroke Association, ischemic strokes account ... continues to enroll qualified patients in the study, ... Intravenous Administration of Allogeneic Mesenchymal Stem Cells and ...
    (Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
    (Date:12/24/2014)... YORK and LONDON , ... global orthopedic industry are expected to grow at an ... in terms of value and volume. Hip, knee and ... developed world while in emerging economies they have a ... rates are challenging the use of composites. Non-metallic orthopedic ...
    Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
    ... Jan. 2, 2012 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... call on Tuesday, January 3, 2012 at 8:30 a.m. Eastern ... ongoing patent litigation with Genentech, Inc., a member of the ... Conference Call InformationDomestic Dial-in Number: (888) 660-6127 International Dial-in Number: ...
    ... 30, 2011 Four free stock picks are being made ... highlights one Zacks #1 Rank Strong Buy or a Zacks ... styles of investing: Aggressive Growth, Growth & Income, Momentum, and ... The four highlighted picks are: Chemtura Corporation  (NYSE: ...
    Cached Medicine Technology:Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation 2Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 2Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 3Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 4
    (Date:12/25/2014)... (PRWEB) December 26, 2014 The ... CAGR of 7.2% to reach $5,756.0 million by ... the microscopy market. The electron microscopes product segment ... the forecast period. , Rising focus on nanotechnology, ... growth of the microscopy market. , Get Full ...
    (Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
    (Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
    (Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... receive effective, less expensive care from a clinic that functions ... of dedicated health care professionals, a new study shows. ... either hospitalization or a trip to the emergency room when ... the University of Texas in Houston versus usual care, according ...
    (Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the ... the business has introduced its new collection of 2015 ... , The new prom outfits are guaranteed to contain ... They are specially designed for 2015. Anyone who wants ... visit its website before Jan. 26, 2015, the deadline ...
    Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
    ... no secret that UVB radiation from the sun causes ... American Journal of PhysiologyRegulatory, Integrative and Comparative Physiology ... formation of wrinkles by lessening tissue damage done by ... were placed in an oxygen chamber after exposure to ...
    ... studies have found that the personality trait impulsivity, ... behaviors, is associated with alcohol use and alcohol-use ... and young adulthood. Some, however, do not "mature ... have found that individuals who exhibited the largest ...
    ... ... Coffee Creamers Ready for Distribution to Natural Food Stores and Mainstream Supermarkets Coast-to-Coast. Made ... ... Green Rabbit, LLC, the parent company of MimicCreme®, announced today the release of its ...
    ... Research Foundation (NRF) of Singapore has announced that the ... universities that have been selected to participate in research ... Excellence and Technological Enterprise) program. The Hebrew ... mechanisms of inflammation. The research aims to accelerate ...
    ... HealthDay Reporter , MONDAY, June 28 (HealthDay News) ... at helping premenopausal women keep from gaining more weight, a ... pounds off such women who are overweight or obese, said ... the department of nutrition at the Harvard School of Public ...
    ... , ... cities in the country by the Natural Resources Defense Council. Scottsdale has also seen an ... , ... Scottsdale has been ranked among the greenest cities in the United States by the National ...
    Cached Medicine News:Health News:Hyperoxia may slow formation of wrinkles 2Health News:Large decline in impulsivity in early adulthood related to decrease in alcohol consumption 2Health News:MimicCreme Announces the Release of its Dairy-Free Whipping Cream - HealthyTop and Two New Flavored Coffee Creamers. 2Health News:Hebrew University added to Singapore research program 2Health News:A Little Biking May Help Premenopausal Women Stay Slim 2Health News:A Little Biking May Help Premenopausal Women Stay Slim 3Health News:A Little Biking May Help Premenopausal Women Stay Slim 4Health News:Scottsdale Named One of US' Greenest Cities, Green Building Permits on the Rise 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: